Clinical Trials on Chronic Pulmonary Aspergillosis

Total 36876 results

Unity Health Toronto

Recruiting

Personalized Smoking Cessation Infographic in COPD

Smoking Cessation | Chronic Obstructive Pulmonary Disease (COPD)

Canada
Jie Li
Binzhou Medical University

Completed

Comparison of HFNC With NIV in Weaning COPD

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation

China
Heidelberg University
Pfizer

Unknown

Diagnostic Study of Biomarkers in BAL of ICU Patients With Lung Infiltrates

Mechanical Ventilation | Biomarker | Diagnostics | INvasive Aspergillosis | Lung Infiltrates

Germany
Gilead Sciences

Completed

Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment

Invasive Aspergillosis | Other Fungal Infections
AstraZeneca

Completed

Realize the Current Situation of COPD Patients in China (REAL)

Chronic Obstructive Pulmonary Disease COPD

China
Pearl Therapeutics, Inc.

Completed

A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPD

COPD, Chronic Obstructive Pulmonary Disease

Belgium
University of Aarhus
Aarhus University Hospital

Terminated

Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration

Invasive Aspergillosis

Denmark
Wuhan Union Hospital, China

Recruiting

The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data (COPD)

Copd | Acute Exacerbation of Chronic Obstructive Pulmonary Disease

China
AstraZeneca
MedImmune LLC

Completed

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History (TERRANOVA)

Moderate to Very Severe Chronic Obstructive Pulmonary Disease

United States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
AstraZeneca
MedImmune LLC

Completed

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History (GALATHEA)

Moderate to Very Severe Chronic Obstructive Pulmonary Disease

United States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
AstraZeneca

Completed

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis (FRONTIER-4)

Chronic Obstructive Pulmonary Disease (COPD) | Chronic Bronchitis

United States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
AstraZeneca

Recruiting

A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD

COPD (Chronic Obstructive Pulmonary Disease)

United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Canada, India, Bulgaria, Poland
Chulalongkorn University

Not yet recruiting

Efficacy and Safety of Beta-glucan Supplement in Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease Patients
Hoffmann-La Roche

Recruiting

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (ARNASA)

Chronic Obstructive Pulmonary Disease (COPD)

United States, China, Spain, Italy, Germany, Belgium, Korea, Republic of, Poland, Taiwan, Israel, New Zealand, Sweden, United Kingdom, Japan, Czechia, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, Brazil, Fran... and more
NanoVation

Completed

Clinical Evaluation of SenseGuard™ to Detect Respiratory Changes, During Home Monitoring of Subjects With High Risk of AECOPD.

Chronic Obstructive Pulmonary Disease (COPD)

Israel
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects

Chronic Obstructive Pulmonary Disease (COPD) | COPD

United Kingdom
AstraZeneca
Amgen

Completed

Tezepelumab COPD Exacerbation Study (COURSE)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada, Denmark, France, United Kingdom, Korea, Republic of, Germany, Israel, Spain, Netherlands
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI); University of Michigan; Duke... and other collaborators

Completed

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2) (CAPTURE)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Chronic Obstructive Pulmonary Disease (COPD)

China
University of Parma
Chiesi Farmaceutici S.p.A.

Not yet recruiting

Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE) (EFFICACE)

COPD, Chronic Obstructive Pulmonary Disease

Italy
Imperial College London
National Institute for Health Research, United Kingdom

Completed

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

ASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTS

United Kingdom
University Hospital, Ghent

Completed

Autonomic Function in Patients With COPD

Autonomic Function in Patients With Chronic Obstructive Pulmonary Disease

Belgium
Shanghai Zhongshan Hospital
Ruijin Hospital; The First Affiliated Hospital of Guangzhou Medical University

Completed

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract (PAEAN)

Chronic Obstructive Pulmonary Disease (COPD)

China
AstraZeneca

Completed

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Nephron Pharmaceuticals Corporation
Rho, Inc.

Completed

Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Augusta University

Completed

Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease (COPD-LT)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Turino, Gerard, M.D.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Zurich

Completed

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance

Chronic Obstructive Pulmonary Disease (COPD)

Switzerland
Sunovion

Terminated

A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Zurich
National Center of Cardiology and Internal Medicine named after academician...

Completed

Altitude Related Illness In Patients With Respiratory Disease

Chronic Obstructive Pulmonary Disease (COPD)

Kyrgyzstan
AstraZeneca

Completed

Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

Chronic Obstructive Pulmonary Disease (COPD)

Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
AstraZeneca

Completed

Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Southeast University, China

Completed

Is it Necessary to Set External PEEP in AECOPD Patients

Acute Exacerbation Chronic Obstructive Pulmonary Disease

China
Novartis Pharmaceuticals

Completed

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) (QUANTIFY)

Chronic Obstructive Pulmonary Disease (COPD)

Germany
AstraZeneca

Completed

The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Poland
Odense University Hospital
Region of Southern Denmark

Completed

Early Telemedicine Training in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
AstraZeneca

Completed

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Chronic Obstructive Pulmonary Disease, COPD

Sweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain
Emphycorp
Cellular Sciences, inc.

Completed

Sodium Pyruvate Therapy in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
Huashan Hospital

Unknown

Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD (REASON)

Microbiome | Acute Exacerbation of Chronic Obstructive Pulmonary Disease

China
University of Nove de Julho

Completed

Photobiomodulation Therapy in Exercise Capacity Assessed by 6MST in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD

Brazil
Cairo University

Recruiting

Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD

Chronic Obstructive Pulmonary Disease Moderate

Egypt
AstraZeneca

Active, not recruiting

An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD. (CRESCENDO)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Denmark, Italy, United Kingdom, Canada, Germany, Turkey, Argentina, South Africa, Spain, Poland, Bulgaria, Mexico, Netherlands
Guy's and St Thomas' NHS Foundation Trust

Suspended

Efficacy of an Advanced Auto-titrating NIV in COPD

Chronic Obstructive Pulmonary Disease Severe

United Kingdom
Zhujiang Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Guangzhou Institute... and other collaborators

Completed

Surface EMGdi Evaluate the Efficacy of Pulmonary Rehabilitation in Patients With COPD: a Multi Center Prospective Study

Chronic Obstructive Pulmonary Disease (COPD)

China
Zhujiang Hospital

Completed

Effects of Different Modes of Respiratory MuscleTraining on Respiratory Mechanics and NRD in Patient With Stable COPD.

Chronic Obstructive Pulmonary Disease (COPD)

China
Reham Mohammed Elmorshedy

Completed

Ventilator Asynchrony as a Predictor of Weaning Failure

Chronic Obstructive Pulmonary Disease(COPD)

Egypt
AstraZeneca

Completed

Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
Verona Pharma plc

Completed

The Effects of RPL554 in Addition to Tiotropium in COPD Patients

Chronic Obstructive Pulmonary Disease Moderate
Schön Klinik Berchtesgadener Land
ResMed

Completed

Effects of Different Oxygen Devices in Hypoxemic COPD Patients

Chronic Obstructive Pulmonary Disease Severe

Germany
Fondazione Don Carlo Gnocchi Onlus
Catholic University of the Sacred Heart

Completed

Relaxation Training for People With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Italy

Clinical Trials on Chronic Pulmonary Aspergillosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations